Community Home

Dear Colleagues,

We are delighted to welcome you to the AAPS Formulation & Delivery Community, established as part of AAPS’ new science‑focused Community structure effective March 25, 2026

This Community brings together a diverse and global group of scientists working across formulation science, drug delivery technologies, and enabling platforms, spanning early development through commercialization. Our shared mission is to foster scientific excellence, meaningful collaboration, and impactful programming that advances the pharmaceutical sciences and supports the evolving needs of our members.

The Formulation & Delivery Community builds on the strong foundations and scientific legacies of several former Communities. We are committed to ensuring continuity where it matters, while also creating space for new ideas, cross‑disciplinary engagement, and emerging areas of science.

As Chair and Vice Chair, we look forward to working with you to shape a vibrant, inclusive, and forward‑looking Community. In the months ahead, we will be engaging members around scientific initiatives, programming opportunities, and avenues for active participation and leadership within AAPS.

We warmly welcome your ideas, perspectives, and involvement, and we look forward to connecting with you as we collectively build and grow this Community.

With best regards,

Sandip Tiwari, PhD
Chair, Formulation & Delivery Community
American Association of Pharmaceutical Scientists (AAPS)

Vivek Gupta, PhD, FAAPS
Vice Chair, Formulation & Delivery Community
American Association of Pharmaceutical Scientists (AAPS)

AAPS joins STEM organizations from across the breadth of the sciences in recognizing Peer Review Week, September 15-19, 2025. This week-long celebration highlights the value of peer review in ensuring credibility in research and this year's theme is "Rethinking Peer Review in the AI Era."

In recognition of Peer Review Week, AAPS will open the eLearning webinars, “Publish or Perish: Peer Review in the Pharmaceutical Sciences” and “Understanding the 'Dreaded' Manuscript Review Process” to non-members for a limited time, along with the opening plenary from the 2025 PharmSci 360. This session featured a panel discussion (starts at 48:00) with Ivan Oransky, M.D., Co-founder of Retraction Watch and Colby Vorland, Ph.D., Assistant Research Scientist at the Indiana University School of Public Health-Bloomington.

Through its four peer-reviewed journals (The AAPS Journal, AAPS PharmSciTech, Pharmaceutical Research, and AAPS Open), AAPS supports ethical, credible science with the help of hundreds of scientist-volunteers who share their time and expertise by participating in peer review. Independent peer reviewers for these publications are critical to assuring the quality of scientific research used in the development of products and therapies that improve global health.

Experience cutting-edge scientific content at #PharmSci360, November 9-12, in San Antonio, along with #professionaldevelopment sessions and opportunities at #Careers360 in our Solution Center.

⏰ Today is the final day for Early Bird Pricing! Register today and save. ⏰

AAPS is pleased to announce that our members have elected new leaders to the AAPS Board of Directors.

Congratulations to President-elect @Otilia Koo, PhD, FAAPS, Novo Nordisk, and Members-at-Large @Carl Allenspach, Ph.D., Bristol Myers Squibb and @Kevin Litwiler, Ph.D., OnKure Therapeutics.